Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Off-label"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 11979
Tytuł:
Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use.
Autorzy:
Conti F; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.
Moratti M; Specialty School of Paediatrics, University of Bologna, 40138 Bologna, Italy.
Leonardi L; Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Catelli A; Specialty School of Paediatrics, University of Bologna, 40138 Bologna, Italy.
Bortolamedi E; Specialty School of Paediatrics, University of Bologna, 40138 Bologna, Italy.
Filice E; Department of Pediatrics, Maggiore Hospital, 40133 Bologna, Italy.
Fetta A; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria dell'Età Pediatrica, 40139 Bologna, Italy.
Fabi M; Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Facchini E; Pediatric Oncology and Hematology Unit 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cantarini ME; Pediatric Oncology and Hematology Unit 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Miniaci A; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cordelli DM; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria dell'Età Pediatrica, 40139 Bologna, Italy.
Lanari M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pession A; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.
Zama D; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Oct 07; Vol. 12 (19). Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Off-Label Use*
Immunoglobulins, Intravenous*/therapeutic use
Humans ; Child ; Anti-Inflammatory Agents/therapeutic use ; SARS-CoV-2 ; Immunomodulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Off-label DaT-SCAN use: a single-center, real-world study.
Autorzy:
Avena R; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Neuroscience Section, University of Salerno, 84131, Salerno, Italy.
Picillo M; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Neuroscience Section, University of Salerno, 84131, Salerno, Italy.
Pellecchia MT; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Neuroscience Section, University of Salerno, 84131, Salerno, Italy.
Barone P; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Neuroscience Section, University of Salerno, 84131, Salerno, Italy.
Erro R; Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', Neuroscience Section, University of Salerno, 84131, Salerno, Italy. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Jul; Vol. 44 (7), pp. 2579-2580. Date of Electronic Publication: 2023 Mar 09.
Typ publikacji:
Letter
MeSH Terms:
Off-Label Use*
Tomography, Emission-Computed, Single-Photon*
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience.
Autorzy:
Fontanals S; Pharmacy Department, Catalan Institute of Oncology (ICO)- Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Medicine, Universitat de Barcelona (UB), ICO, Hospitalet de Llobregat, Barcelona, Spain.
Esteve A; Research Management Unit (UGR), Catalan Institute of Oncology (ICO), Medical Oncology Department, ICO-Badalona, Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
González A; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
Ibáñez C; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Blanquerna Ramon Llull University, School of Health Sciences, ICO, Hospitalet de Llobregat, Barcelona, Spain.
Mesía R; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
Clopés A; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Health Sciences, Blanquerna Ramon Llull University, ICO, Hospitalet de Llobregat, Barcelona, Spain.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1167.
Typ publikacji:
Journal Article
MeSH Terms:
Immune Checkpoint Inhibitors*/therapeutic use
Neoplasms*/drug therapy
Male ; Humans ; Female ; Middle Aged ; Off-Label Use ; Medical Oncology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Off-Label Use of an External Hand Fixator for Craniomaxillofacial Fractures—An Anatomical Feasibility Study.
Autorzy:
Wichlas, Florian (AUTHOR)
Necchi, Marco (AUTHOR)
Gruber, Teresa (AUTHOR)
Hofmann, Valeska (AUTHOR)
Deininger, Susanne (AUTHOR)
Deininger, Sebastian Hubertus Markus (AUTHOR)
Deluca, Amelie (AUTHOR)
Steidle-Kloc, Eva (AUTHOR)
Pruszak, Jan (AUTHOR)
Wittig, Jörn (AUTHOR)
Deininger, Christian (AUTHOR)
Pokaż więcej
Źródło:
Bioengineering (Basel). Mar2024, Vol. 11 Issue 3, p279. 16p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Off-label use of large diameter Concerto fibered coils through a 0.017 inch microcatheter for transvenous embolization of indirect carotid-cavernous fistulas: two case reports.
Autorzy:
Hsieh, Justin T. (AUTHOR)
Chia, Ghim Song (AUTHOR)
Wong, Chen Pong (AUTHOR)
Lim, Winston Eng Hoe (AUTHOR)
Wen, David W. (AUTHOR)
Pokaż więcej
Źródło:
Journal of Medical Case Reports. 2/5/2024, Vol. 18 Issue 1, p1-4. 4p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Judicial and legislative practice and related suggestions on off-label drug use in China.
Autorzy:
Si W; Department of International Medical Services, Peking Union Medical College Hospital, Beijing, China. .
Ma P; Department of International Medical Services, Peking Union Medical College Hospital, Beijing, China.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Mar 30; Vol. 23 (1), pp. 312. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Liability, Legal*
Off-Label Use*
Humans ; China ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Massive presence of off-label medicines in Danish neonatal departments: A nationwide survey using national hospital purchase data.
Autorzy:
Gade C; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Trolle S; The Hospital Pharmacy, Copenhagen University Hospital Capital region of Denmark, Copenhagen, Denmark.
Mørk ML; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Lewis A; Department of Neonatology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Andersen PF; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Jacobsen T; Department of Neonatology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Andersen J; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Lausten-Thomsen U; Department of Neonatology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Feb; Vol. 11 (1), pp. e01037.
Typ publikacji:
Journal Article
MeSH Terms:
Off-Label Use*
Premature Birth*
Infant, Newborn ; Female ; Humans ; Hospitals ; Practice Patterns, Physicians' ; Denmark
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Off-label intravitreal Brolucizumab in the management of central serous chorioretinopathy.
Autorzy:
Panigrahi PK; Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be) University, 8-Kalinga Nagar, Bhubaneswar, Odisha, India.
Hanisha D
Pokaż więcej
Źródło:
Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Feb 01; Vol. 72 (2), pp. 297-298. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Central Serous Chorioretinopathy*/diagnosis
Central Serous Chorioretinopathy*/drug therapy
Humans ; Off-Label Use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Bevacizumab/therapeutic use ; Tomography, Optical Coherence ; Fluorescein Angiography ; Intravitreal Injections
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment of neuropathic pain using off-label pharmacological treatments.
Autorzy:
Abd-Elsayed A; Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Gilligan C; Brigham and Women's Spine Service Line, Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Pain practice : the official journal of World Institute of Pain [Pain Pract] 2023 Mar; Vol. 23 (3), pp. 325-327. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Off-Label Use*
Neuralgia*/therapy
Humans ; Analgesics/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rapid Whole Genome Sequencing Diagnoses and Guides Treatment in Critically Ill Children in Belgium in Less than 40 Hours.
Autorzy:
Lumaka A; Human Genetic Laboratory, GIGA Institute, University of Liège, 4000 Liège, Belgium.; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Fasquelle C; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Debray FG; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Alkan S; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.; Neuropediatric Division, CHU de Liège-CHR de la Citadelle, University of Liège, 4000 Liège, Belgium.
Jacquinet A; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Harvengt J; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Boemer F; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Mulder A; Department of Pediatrics, Division of Pediatric Critical Care Medicine, CHC Mont-Légia, 4000 Liège, Belgium.
Vaessen S; Neuropediatric Division, CHU de Liège-CHR de la Citadelle, University of Liège, 4000 Liège, Belgium.
Viellevoye R; Neonatology Division, CHU de Liège-CHR de la Citadelle, University of Liège, 4000 Liège, Belgium.
Palmeira L; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Charloteaux B; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Brysse A; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Bulk S; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Rigo V; Neonatology Division, CHU de Liège-CHR de la Citadelle, University of Liège, 4000 Liège, Belgium.
Bours V; Human Genetic Laboratory, GIGA Institute, University of Liège, 4000 Liège, Belgium.; Center for Human Genetics, Centre Hospitalier Universitaire, 4032 Liège, Belgium.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 16; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Critical Illness*
Off-Label Use*
Infant, Newborn ; Humans ; Child ; Belgium ; Whole Genome Sequencing/methods ; Intensive Care Units, Pediatric
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Off-label use information in electronic drug information resources.
Autorzy:
Rothgeb A; , Staff Pharmacist, Kroger, Fort Wayne, IN. At the time the work was completed, Dr. Rothgeb was a student at Manchester University, Fort Wayne, IN.
Beckett RD; , Clinical Standardization Coordinator, Parkview Health, Fort Wayne, IN. At the time the work was completed, Dr. Beckett was faculty at Manchester University, Fort Wayne, IN.
Daoud N; , Staff Pharmacist, CAZMA, Dearborn, MI. At the time the work was completed, Dr. Daoud was a student at Manchester University, Fort Wayne, IN.
Pokaż więcej
Źródło:
Journal of the Medical Library Association : JMLA [J Med Libr Assoc] 2022 Oct 01; Vol. 110 (4), pp. 471-477.
Typ publikacji:
Journal Article
MeSH Terms:
Off-Label Use*
Drug Information Services*
United States ; Databases, Factual
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Update to Gabapentinoid Use in the United States, 2002-2021.
Autorzy:
Johansen ME; Grant Family Medicine, OhioHealth, Columbus, Ohio .
Maust DT; Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
Pokaż więcej
Źródło:
Annals of family medicine [Ann Fam Med] 2024 Jan-Feb; Vol. 22 (1), pp. 45-49.
Typ publikacji:
Journal Article
MeSH Terms:
Chronic Pain*/drug therapy
Gabapentin*/therapeutic use
Adult ; Humans ; United States ; Off-Label Use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Off-label Prescription in Paediatric Dermatology: A Retrospective Observational Study in a Tertiary Hospital.
Autorzy:
Couselo-Rodríguez C; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Sergas-Uvigo, Spain. .
Batalla A; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Sergas-Uvigo, Spain.
Martínez-Fernández S; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Sergas-Uvigo, Spain.
Dávila-Pousa C; Department of Pharmacy. University Hospital of Pontevedra, Pontevedra, Spain.
Soto-García D; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Sergas-Uvigo, Spain.
Vilanova-Trillo L; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Sergas-Uvigo, Spain.
Flórez Á; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Sergas-Uvigo, Spain.
Pokaż więcej
Źródło:
Acta dermato-venereologica [Acta Derm Venereol] 2023 Dec 11; Vol. 103, pp. adv11937. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Dermatology*
Hemangioma*/drug therapy
Warts*
Child ; Humans ; Off-Label Use ; Prescriptions ; Tertiary Care Centers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere.
Autorzy:
Luo Y; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Fan Q; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Yu Y; School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Zhang L; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Dong L; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China.
Luo H; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Sep 13; Vol. 12 (1), pp. 15363. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alprostadil*/therapeutic use
Off-Label Use*
China ; Humans ; Microspheres ; Pharmacists
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children.
Autorzy:
Schaffer AL; Centre for Big Data Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.
Bruno C; Centre for Big Data Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.
Buckley NA; Biomedical Informatics and Digital Health, The University of Sydney, Sydney, New South Wales, Australia.; NSW Poisons Information Centre, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Cairns R; NSW Poisons Information Centre, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.; Faculty of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia.
Litchfield M; Centre for Big Data Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.
Paget S; The Children's Hospital at Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.
Zoega H; Centre for Big Data Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Nassar N; The Children's Hospital at Westmead Clinical School, The University of Sydney, Sydney, New South Wales, Australia.; Menzies Centre for Health Policy, The University of Sydney, Sydney, New South Wales, Australia.
Pearson SA; Centre for Big Data Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.; Menzies Centre for Health Policy, The University of Sydney, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Paediatric and perinatal epidemiology [Paediatr Perinat Epidemiol] 2022 Sep; Vol. 36 (5), pp. 726-737. Date of Electronic Publication: 2022 Feb 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Bacterial Agents*
Off-Label Use*
Australia/epidemiology ; Child ; Humans ; Infant ; Practice Patterns, Physicians' ; Prevalence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? - a systematic review with GRADE approach.
Autorzy:
van Huizen AM; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Vermeulen FM; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bik CMJM; General Practitioner (Self-employed), Eindhoven, The Netherlands.
Borgonjen R; Department of Dermatology, Gelderland Valley Hospital, Ede, The Netherlands.
Karsch SAT; Department of Family Medicine, UMC Utrecht, Utrecht, The Netherlands.
Kuin RA; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Gerbens LAA; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Spuls PI; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2022 Jun; Vol. 33 (4), pp. 1947-1966. Date of Electronic Publication: 2021 Aug 23.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Methotrexate*/therapeutic use
Off-Label Use*
GRADE Approach ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.
Autorzy:
Pfarr KM; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Krome AK; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Bonn, Germany.
Al-Obaidi I; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Batchelor H; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Vaillant M; Competence Center for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Grand Duchy of Luxembourg.
Hoerauf A; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Opoku NO; Department of Epidemiology and Biostatistics School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana.
Kuesel AC; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), World Health Organization, Geneva, Switzerland. .
Pokaż więcej
Źródło:
Parasites & vectors [Parasit Vectors] 2023 Oct 31; Vol. 16 (1), pp. 394. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Ivermectin*/therapeutic use
Anti-Infective Agents*/therapeutic use
Humans ; Rifampin ; Doxycycline ; Fluconazole ; Off-Label Use ; Drug Combinations ; Neglected Diseases/drug therapy ; Neglected Diseases/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real-world treatment outcomes of medicines used in special situations (off-label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution.
Autorzy:
Fontanals S; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Medicine, Universitat de Barcelona (UB), Barcelona, Spain.
Esteve A; Research Management Unit (Unitat de Gestió de la recerca: UGR), Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
González A; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
Ibáñez C; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, School of Health Sciences, Blanquerna Ramon Llull University, Barcelona, Spain.
Martínez J; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Barcelona, Spain.
Mesía R; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
Clopés A; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Health Sciences, Blanquerna Ramon Llull University, Barcelona, Spain.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (16), pp. 17112-17125. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Compassionate Use Trials*
Neoplasms*/drug therapy
Adult ; Humans ; Female ; Retrospective Studies ; Off-Label Use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 11979

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies